Skip to main content

News

In the News
Feb 13, 2024

The pipeline for pandemic products is bare. Here’s why it matters

There are barely any therapeutics, vaccines, and diagnostics in the clinical pipeline for diseases with pandemic potential.

Read more
Press Release
Jan 24, 2024

INTREPID Alliance Releases Review of Antiviral Compounds in Clinical Development to Contribute to Collaborative Efforts in Pandemic Preparedness

Global landscape analysis identifies strengths and gaps in R&D pipeline to inform international pandemic preparedness efforts

Read more
Statement
Sep 20, 2023

Accelerating antiviral development is central to pandemic preparedness

As leaders and health experts from across the world gather in New York for the UN General Assembly, they will be considering three issues that are critical to the future of global health and global health security.

Read more
In the News
Aug 2, 2023

INTREPID’s new strategy to help build a pandemic war chest

The INTREPID Alliance has abandoned its fundraising plans, but not its mission to expedite antiviral development for future pandemics.

Read more
In the News
Jul 26, 2023

New Industry Group Seeking Out Antiviral Candidates For Future Pandemics

An alliance of seven R&D-based pharma firms is putting collaboration and partnerships at the center of the search for new antivirals against emerging pathogens.

Read more
Press Release
Jul 20, 2023

Pharmaceutical companies come together to accelerate the development of innovative antiviral treatments in preparation for future pandemics

Seven innovative pharmaceutical companies have established the INTREPID Alliance, with the goal of accelerating progress in discovery and development of new antiviral treatments for future pandemics.

Read more